13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neurodevelopmental Specialists
Neurodevelopmental specialists focus on the assessment, diagnosis, and management of neurological disorders that affect the developing nervous system. They work with individuals from birth through adolescence, identifying conditions such as autism spectrum disorder, attention deficit hyperactivity disorder (ADHD), and developmental delay. These specialists use a variety of diagnostic tools, including neuroimaging, genetic testing, and cognitive assessments, to determine the root causes of developmental issues. By understanding how the brain matures and how different factors influence neural development, they provide crucial insights into early interventions. They also explore how genetic, environmental, and prenatal factors contribute to developmental disorders, offering guidance on personalized therapies and treatments. Neurodevelopmental specialists collaborate with pediatricians, psychologists, and speech-language therapists to create individualized care plans that improve a child's social, cognitive, and motor skills. Their research efforts focus on understanding the neurological basis of developmental disorders, leading to the development of new therapies and interventions that promote neural plasticity and support learning. By identifying early markers of developmental challenges, neurodevelopmental specialists can prevent or minimize the long-term impact of these conditions on individuals’ lives, helping them reach their full potential.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States